openPR Logo
Press release

ProBio offers ADCC assay (SC1544) and CDC assay (SC1545) services for customers

11-28-2024 12:32 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Website Servicer Co.,Ltd
ProBio offers ADCC assay (SC1544) and CDC assay (SC1545)

ADCC & CDC assays

Endpoint-Based, and Speedy

Dramatic improvement of ADCC [https://www.probiocdmo.com/add-adcc-cdc-assay.html] by using recombinant NK cells

Antibody therapy has been proven to be highly powerful for cancer treatment. Two important mechanisms used by antibody drugs to kill targeted tumor cells are Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), and Complement Dependent Cytotoxicity (CDC). ProBio is pleased to present to customers both a PBMC-based ADCC assay [https://www.probiocdmo.com/add-adcc-cdc-assay.html] and natural kill cell-based ADCC assay. The readout is endpoint-driven (target cell lysis). The CDC assay [https://www.probiocdmo.com/add-adcc-cdc-assay.html] uses normal human serum as the source of complement. By implementing strict QC standards, ProBio can provide the assurance of the efficacy and potency profiles of the therapeutic antibodies.

ADCC mechanism

Image: https://www.probiocdmo.com/img/gsprobio/addc-mechanism.jpg

ADCC Case Study

Image: https://www.probiocdmo.com/img/gsprobio/addc-1.jpg

Figure 1 Concentration-dependent study of Herceptin-mediated ADCC on SK-BR-3 cells by using PBMC as effector cells (human IgG as negative control)

Image: https://www.probiocdmo.com/img/gsprobio/addc-2.jpg?v=1

Figure 2 Concentration-dependent study of Erbitux-mediated ADCC on A431 cells by using freshly isolated NK cells as effector cells (Rituxan as negative control)

Image: https://www.probiocdmo.com/img/gsprobio/addc-3.jpg

Figure 3 Concentration-dependent study of Humira-mediated ADCC on CHO/tm TNF- cells by using PBMC as effector cells (human IgG as negative control). CHO/tm TNF- was a cell line stably expressed membrane bound TNF- at which the proteolytic cleavage site was modified.

CDC Mechanism

Image: https://www.probiocdmo.com/img/gsprobio/20141009102428.png

Case Study 1: Rituxan elicited CDC lysis of two CD20-positive leukemia cell lines

Image: https://www.probiocdmo.com/img/gsprobio/adcc20131112154716.jpg

Image: https://www.probiocdmo.com/img/gsprobio/adcc20131112154732.jpg

NHS: normal human serum

Key features of ProBio's ADCC & CDC assay services [https://www.probiocdmo.com/add-adcc-cdc-assay.html]

* Data readout is driven by the target cell lysis endpoint
* High throughput assay service for bulk antibody drug screening
* Large panel of target tumor cell lines free of charge to be used in ADCC assays
* Ready-to-go ADCC assay format for at least 4 targets, HER2/ErbB2, CD20, EGFR, and TNF
* Ready-to-go CDC assay format for at least 2 targets, CD20 and TNF

Media Contact
Company Name: ProBio CDMO
Email: Send Email [http://www.universalpressrelease.com/?pr=probio-offers-adcc-assay-sc1544-and-cdc-assay-sc1545-services-for-customers]
Phone: 1-877-436-7274 (Toll-Free)
Country: United States
Website: https://www.probiocdmo.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ProBio offers ADCC assay (SC1544) and CDC assay (SC1545) services for customers here

News-ID: 3761908 • Views:

More Releases from Getnews

KC Roofing, LLC Expands Comprehensive Roofing Services in Glenwillow
KC Roofing, LLC Expands Comprehensive Roofing Services in Glenwillow
Image: https://www.globalnewslines.com/uploads/2025/01/1737653185.jpg KC Roofing, LLC, a trusted name in roofing solutions, is proud to announce the expansion of its comprehensive roofing services to serve residents and businesses in Glenwillow better. The company, renowned for its commitment to quality craftsmanship and customer satisfaction, is poised to meet the growing demand for reliable roofing services in the area. With over a decade of industry experience, KC Roofing, LLC has built a reputation for
Dr. Elra Morgan Publishes Three Amazon #1 Best Sellers, Revolutionizing Chiropractic and Laser Medicine
Dr. Elra Morgan Publishes Three Amazon #1 Best Sellers, Revolutionizing Chiropra …
Dr. Elra Morgan, a celebrated chiropractic physician, educator, and author, has achieved an extraordinary milestone: three of his books have become Amazon #1 Best Sellers in the categories of Chiropractic, Alternative Medicine, and Lasers in Medicine. Image: https://authoritypresswire.com/wp-content/uploads/2025/01/3.jpg The Healthy Alternative, You've Got a Lot of Nerve!... Discs & Joints, and the co-authored Aligning Wellness: True Stories of Healing and Transformation from Leading Doctors, Dr. Elra Morgan is cementing his legacy as
Dr. Gerardo Myrin to Launch TV Streaming Commercial on Championship Game Day
Dr. Gerardo Myrin to Launch TV Streaming Commercial on Championship Game Day
Image: https://www.globalnewslines.com/uploads/2025/01/1737653321.jpg Dr. Gerardo Myrin, a board-certified, fellowship-trained orthopedic surgeon [https://www.google.com/maps/place/Gerardo+Myrin,+MD+-+Robotic+Knee+and+Hip+Replacement+Surgeon/@35.4509025,-97.6602406,12z/data=!3m1!5s0x87b21aee76519b23:0x56005d1d140678a0!4m7!3m6!1s0x87b21348024eb91b:0x579db2e3a6282b0c!8m2!3d35.5255867!4d-97.585164!15sCg1HZXJhcmRvIG15cmlukgESb3J0aG9wZWRpY19zdXJnZW9u4AEA!16s%2Fg%2F11g1b0tq_5?entry=tts&g_ep=EgoyMDI1MDEyMC4wIPu8ASoASAFQAw%3D%3D] at INTEGRIS Health Baptist Medical Center in Oklahoma City, is set to debut a TV streaming commercial campaign on the day of the upcoming NFL Championship games for the AFC and NFC. The 15-second commercial, airing throughout the day on major streaming platforms [https://myonlinebillboard.com/], aims to reach individuals suffering from knee and hip pain, offering expert care and innovative solutions. Key
Transforming Mental Health Treatments and Expanding Clinic Networks: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
Transforming Mental Health Treatments and Expanding Clinic Networks: NRx Pharmac …
Image: https://www.globalnewslines.com/uploads/2025/01/1737669812.jpg NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP), a clinical-stage biopharmaceutical leader, is at the forefront of addressing critical mental health challenges, including suicidal depression, bipolar disorder, and PTSD. Through groundbreaking therapeutics and strategic investments, the company aims to revolutionize care for millions while delivering significant returns for investors. A Breakthrough in Mental Health Treatment NRX-101, the company's flagship product, is an FDA-designated investigational Breakthrough Therapy targeting suicidal treatment-resistant bipolar depression and chronic

All 4 Releases


More Releases for ADCC

Global Biosimilar Testing and Development Services Market Report Overview 2019-2 …
Market Research Hub (MRH) has actively included a new research study titled “Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until
Construction in the UAE - Key Trends and Opportunities to 2023 | Top Companies - …
Recovery in the country's construction industry is expected to continue over the forecast period (2019-2023), driven by a declining budget deficit and improving investor confidence, which will support new investments in residential, energy and utilities, infrastructure and commercial construction projects. Furthermore, an increase in crude oil production and government efforts to diversify the economy are expected to drive investment in the UAE construction industry over the forecast period. Investments in transport,
Construction in the UAE(United Arab Emirates) - Key Trends and Opportunities to …
Following two years of contraction, the UAE construction industry rebounded in 2018, and registered growth of 4.2% in real terms. Recovery in the country's construction industry is expected to continue over the forecast period (2019-2023), driven by a declining budget deficit and improving investor confidence, which will support new investments in residential, energy and utilities, infrastructure and commercial construction projects. Furthermore, an increase in crude oil production and government efforts to
Biosimilar Testing and Development Services Market 2018 Global Analysis By key P …
Biosimilar Testing and Development Services Market 2018 Wiseguyreports.Com adds “Biosimilar Testing and Development Services Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Report Details: This report provides in depth study of “Biosimilar Testing and Development Services Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Biosimilar Testing and Development Services Market report also provides an in-depth survey of
AeroMACS Advances Worldwide as the Standardized Solution for the Airport Surface
Ground Communication Improvements Enabled by Secure Wireless Broadband Technology to Support the Safety and Regularity of Flights The WiMAX Forum®, the leading nonprofit organization that certifies and promotes the compatibility and interoperability of broadband wireless products based upon IEEE Standard 802.16, continues its efforts to advance the Aeronautical Mobile Airport Communication System (AeroMACS) globally. The WiMAX Forum and its member companies, through a wide variety of worldwide activities, are raising awareness
Autoimmune Disease Diagnostics Market share worth $15bn by 2023
The research report “Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023”, by Global Market Insights, Inc., Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023. Rising lab automation rates enabling faster